These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 26484993)

  • 21. QRS axis and the benefit of cardiac resynchronization therapy in patients with mildly symptomatic heart failure enrolled in MADIT-CRT.
    Brenyo A; Rao M; Barsheshet A; Cannom D; Quesada A; McNitt S; Huang DT; Moss AJ; Zareba W
    J Cardiovasc Electrophysiol; 2013 Apr; 24(4):442-8. PubMed ID: 23252875
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent advances in the optimization of cardiac resynchronization therapy.
    Chandraprakasam S; Mentzer GG
    Curr Heart Fail Rep; 2015 Feb; 12(1):48-60. PubMed ID: 25315038
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factors associated with improvement in utilization of cardiac resynchronization therapy in eligible heart failure patients: findings from IMPROVE HF.
    Shukla A; Curtis AB; Mehra MR; Albert NM; Gheorghiade M; Heywood JT; Liu Y; O'Connor CM; Reynolds D; Walsh MN; Yancy CW; Fonarow GC
    Pacing Clin Electrophysiol; 2013 Apr; 36(4):433-43. PubMed ID: 23380000
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimal role of rest and stress echocardiography in cardiac resynchronization therapy.
    Pons J; Voisine P; Sénéchal M
    Minerva Cardioangiol; 2011 Aug; 59(4):391-406. PubMed ID: 21705999
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiac resynchronization therapy (CRT): clinical trials, guidelines, and target populations.
    Linde C; Ellenbogen K; McAlister FA
    Heart Rhythm; 2012 Aug; 9(8 Suppl):S3-S13. PubMed ID: 22521934
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical effectiveness of cardiac resynchronization and implantable cardioverter-defibrillator therapy in men and women with heart failure: findings from IMPROVE HF.
    Wilcox JE; Fonarow GC; Zhang Y; Albert NM; Curtis AB; Gheorghiade M; Heywood JT; Mehra MR; O'Connor CM; Reynolds D; Walsh MN; Yancy CW
    Circ Heart Fail; 2014 Jan; 7(1):146-53. PubMed ID: 24178311
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of renal insufficiency on long-term clinical outcome in patients with heart failure treated by cardiac resynchronization therapy.
    Hosoda J; Ishikawa T; Matsushita K; Matsumoto K; Kimura Y; Miyamoto M; Ogawa H; Takamura T; Sugano T; Ishigami T; Uchino K; Kimura K; Umemura S
    J Cardiol; 2012 Oct; 60(4):301-5. PubMed ID: 22763383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiac resynchronisation therapy in patients with chronic heart failure.
    Lalani GG; Birgersdotter-Green U
    Heart; 2015 Jul; 101(13):1008-14. PubMed ID: 25882504
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dyssynchrony, contractile function, and response to cardiac resynchronization therapy.
    Knappe D; Pouleur AC; Shah AM; Cheng S; Uno H; Hall WJ; Bourgoun M; Foster E; Zareba W; Goldenberg I; McNitt S; Pfeffer MA; Moss AJ; Solomon SD;
    Circ Heart Fail; 2011 Jul; 4(4):433-40. PubMed ID: 21602574
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of clinical trials evaluating cardiac resynchronization therapy in mild to moderate heart failure.
    Zaręba W
    Cardiol J; 2010; 17(6):543-8. PubMed ID: 21154255
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of weight loss on clinical outcomes in patients implanted with a cardiac resynchronization therapy device-A MADIT-CRT substudy.
    Aktas MK; Zareba W; Huang DT; McNitt S; Polonsky S; Chen L; Stockburger M; Merkely B; Moss AJ; Kutyifa V
    J Card Fail; 2014 Mar; 20(3):183-9. PubMed ID: 24361804
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The prognostic role of right ventricular function in left ventricular disease in the setting of cardiac resynchronization therapy.
    Abdirahman I; Haddad T; Dwivedi G
    Curr Opin Cardiol; 2014 Mar; 29(2):185-91. PubMed ID: 24406447
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of ejection fraction on the clinical response to cardiac resynchronization therapy in mild heart failure.
    Linde C; Daubert C; Abraham WT; St John Sutton M; Ghio S; Hassager C; Herre JM; Bergemann TL; Gold MR;
    Circ Heart Fail; 2013 Nov; 6(6):1180-9. PubMed ID: 24014828
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multispecialty approach: the need for heart failure disease management for refining cardiac resynchronization therapy.
    Tang WH; Boehmer J; Gras D
    Heart Rhythm; 2012 Aug; 9(8 Suppl):S45-50. PubMed ID: 22521929
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma galectin-3 and heart failure outcomes in MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy).
    Stolen CM; Adourian A; Meyer TE; Stein KM; Solomon SD
    J Card Fail; 2014 Nov; 20(11):793-9. PubMed ID: 25106783
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Digoxin therapy and associated clinical outcomes in the MADIT-CRT trial.
    Lee AY; Kutyifa V; Ruwald MH; McNitt S; Polonsky B; Zareba W; Moss AJ; Ruwald AC
    Heart Rhythm; 2015 Sep; 12(9):2010-7. PubMed ID: 26025322
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimizing atrioventricular and interventricular intervals following cardiac resynchronization therapy.
    Nayar V; Khan FZ; Pugh PJ
    Expert Rev Cardiovasc Ther; 2011 Feb; 9(2):185-97. PubMed ID: 21453215
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiac resynchronization therapy restores sympathovagal balance in the failing heart by differential remodeling of cholinergic signaling.
    DeMazumder D; Kass DA; O'Rourke B; Tomaselli GF
    Circ Res; 2015 May; 116(10):1691-9. PubMed ID: 25733594
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A metric for evaluating the cardiac response to resynchronization therapy.
    Ge Y; Ruwald AC; Kutyifa V; McNitt S; Polonsky S; Klein H; Goldenberg I; Solomon SD; Foster E; Zareba W; Moss AJ
    Am J Cardiol; 2014 Apr; 113(8):1371-7. PubMed ID: 24607029
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiac resynchronization therapy reduces the risk of cardiac events in patients with diabetes enrolled in the multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy (MADIT-CRT).
    Martin DT; McNitt S; Nesto RW; Rutter MK; Moss AJ
    Circ Heart Fail; 2011 May; 4(3):332-8. PubMed ID: 21350054
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.